Indefinite Delivery Contract 36C26226D0058

The Department of Veterans Affairs, Veterans Integrated Service Network (VISN) 22, awarded a single-award Indefinite Delivery Contract valued at $3.5 million to Tosoh Bioscience, Inc. (doing business as Tosoh USA) on March 18, 2026, with an ultimate completion date of March 17, 2031. This contract procures Hemoglobin A1c (HbA1c) analyzers and associated cost-per-test services for clinical laboratory operations across four VA medical centers: Loma Linda, Tucson, West Los Angeles, and Albuquerque, California and Arizona. The contract originated from a Request for Quotation (RFQ 36C26226Q0140) issued under Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures on January 20, 2026, with quotations due February 9, 2026. No set-aside designation was used, and the procurement proceeded through full and open competition under NAICS Code 325413 (In-Vitro Diagnostic Substance Manufacturing).

Tosoh Bioscience will deliver FDA-approved hemoglobin analyzers capable of high-performance liquid chromatography or capillary electrophoresis methodology, along with reagents, test cartridges, consumables, and comprehensive support services including 24/7 technical assistance and four-hour emergency response capabilities. The contract supports an estimated annual testing volume of 229,198 HbA1c tests across the four facilities, enabling diabetes diagnosis and management for veteran patients. Deliverables include equipment, cost-per-reportable-result testing services, and maintenance support structured on a firm fixed-price basis. The contract establishes a guaranteed minimum award of $500 and individual delivery order caps of $1,000,000, with performance requirements including standard four-working-day delivery and emergency delivery at no additional cost. Implementation must be completed within 90 days of contract award, with the base year plus four optional one-year renewal periods constituting the five-year performance period.